Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies. [PDF]
Int J Mol Sci, 2020 Chen YS, Hong ZX, Lin SZ, Harn HJ.
europepmc +1 more source
Yemenite-Jewish families with Machado-Joseph disease (MJD/SCA3) share a recent common ancestor. [PDF]
Eur J Hum Genet, 2019 Sharony R +6 more
europepmc +1 more source
The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples. [PDF]
Acta Neuropathol Commun, 2020 Duarte Lobo D +8 more
europepmc +1 more source
Tremor during orthostatism as the initial symptom of Machado–Joseph disease
, 2018 Shinichi Shirai +7 more
openalex +2 more sources
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease. [PDF]
Mol Ther Methods Clin Dev, 2019 Martier R +15 more
europepmc +1 more source
Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease. [PDF]
Mol Neurobiol, 2019 Ashraf NS +6 more
europepmc +1 more source
Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis? [PDF]
Open Neurol J, 2018 Catai LMP +5 more
europepmc +1 more source
Choosing not to know: accounts of non-engagement with pre-symptomatic testing for Machado-Joseph disease. [PDF]
Eur J Hum Genet, 2019 Mendes Á +3 more
europepmc +1 more source
Longitudinal study in patients with Machado-Joseph disease : clinical and neuroimaging correlation
, 2009 ANELYSSA CYSNE FROTA D'ABREU
openalex +1 more source